Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Safety, Pharmacokinetic and Efficacy Study of a y-Secretase Inhibitor, Nirogacestat (PF-03084014), in Children and Adolescents With Progressive, Surgically Unresectable Desmoid Tumors

NCT04195399 is registered in ClinicalTrials.gov with Children's Oncology Group as lead sponsor.

NCT NCT04195399
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04195399 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Safety, Pharmacokinetic and Efficacy Study of a y-Secretase Inhibitor, Nirogacestat (PF-03084014), in Children and Adolescents With Progressive, Surgically Unresectable Desmoid Tumors
Lead sponsor
Children's Oncology Group
Phase
Phase 2
Overall status
Active, not recruiting
Start date
October 7, 2020
Completion date
December 31, 2032
Enrollment
31 (actual)
Sites
98

Conditions

As the registry lists them; a condition with its own page is linked.

desmoid fibromatosis, recurrent desmoid fibromatosis, unresectable desmoid fibromatosis